We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,491 results
  1. Antenatal pyelonephritis: a three-year retrospective cohort study of two Irish maternity centres

    Pyelonephritis affects 1–2% of pregnant women, and is associated with significant maternal and fetal morbidity. Antenatal pyelonephritis has been...

    Rachel Barry, Elaine Houlihan, ... Richard J. Drew in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 01 May 2023
  2. Facklamia hominis pyelonephritis in a pediatric patient: first case report and review of the literature

    Background

    Pyelonephritis is one of the most serious bacterial illnesses during childhood. Gram-negative organisms account for up to 90% of the cases....

    Samantha Pérez-Cavazos, Daniela Cisneros-Saldaña, ... Abiel Mascareñas-De los Santos in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 12 February 2022
  3. Increasing rates of extended-spectrum B-lactamase-producing Escherichia coli and Klebsiella pneumoniae in uncomplicated and complicated acute pyelonephritis and evaluation of empirical treatments based on culture results

    Increasing rates of extended-spectrum beta-lactamase (ESBL) producing E. coli and K. pneumoniae over time made empirical treatment complicated....

    Bircan Kayaaslan, Zeynep Oktay, ... Rahmet Guner in European Journal of Clinical Microbiology & Infectious Diseases
    Article 03 January 2022
  4. Exploring the Therapeutic Efficacy of Zingerone Nanoparticles in Treating Biofilm-Associated Pyelonephritis Caused by Pseudomonas aeruginosa in the Murine Model

    Biofilms of Pseudomonas aeruginosa can cause complicated urinary tract infections especially in people with indwelling catheters which may result in...

    Karuna Sharma, Sunil Kumar Bose, ... Kusum Harjai in Inflammation
    Article 18 September 2020
  5. Modeling the risk of fluoroquinolone resistance in non-severe community-onset pyelonephritis

    Estimating whether the individual probability of being infected by a fluoroquinolone resistant isolate is higher than 10% may help to choose the...

    Antoine Leforestier, Marie-Anne Vibet, ... Eric Batard in European Journal of Clinical Microbiology & Infectious Diseases
    Article 30 January 2020
  6. Distribution of papG alleles among uropathogenic Escherichia coli from reproductive age women

    Background

    Extraintestinal Escherichia coli ( E. coli ) causing urinary tract infections (UTIs), and often referred to as uropathogenic E. coli (UPEC),...

    Timothy Kudinha, Fanrong Kong in Journal of Biomedical Science
    Article Open access 07 September 2022
  7. Study on risk factors, bacterial species, and drug resistance of acute pyelonephritis associated with ureteral stent after percutaneous nephrolithotomy

    The purpose of this study is to explore the risk factors, bacterial species, and drug resistance of acute pyelonephritis (AP) associated with...

    Guo Jiang, Jiang Li, ... Zhang Zhenyang in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 09 October 2020
  8. A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis

    Antibiotic resistance to oral antibiotics recommended for pyelonephritis is increasing. The objective was to determine if there is a pharmacological...

    J. W. S. Cattrall, E. Asín-Prieto, ... A. Kirby in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 07 September 2019
  9. New Cephalosporins: Fifth and Sixth Generations

    New generation (5th) of cephalosporins have been introduced on the market over the last decade to combat methicillin-resistant Staphylococcus aureus...
    Chapter 2023
  10. Clinical effectiveness of oral antimicrobial therapy for acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales

    Infections caused by extended-spectrum β-lactamase - producing Enterobacteriales (ESBL-PE) are commonly treated with intravenous antibiotics. This...

    Si-Ho Kim, Kyoung Ree Lim, ... Kyong Ran Peck in European Journal of Clinical Microbiology & Infectious Diseases
    Article 13 September 2019
  11. Inhibition of COX-2 signaling favors E. coli during urinary tract infection

    Background

    To avoid the overuse of antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), acting via cyclooxygenase (COX) inhibition, have been...

    Soumitra Mohanty, Ciska Lindelauf, ... Annelie Brauner in Journal of Inflammation
    Article Open access 11 September 2023
  12. Clinical impact of perinephric fat stranding detected on computed tomography in patients with acute pyelonephritis: a retrospective observational study

    Perinephric fat stranding (PFS) is often detected on computed tomography (CT) in patients with acute pyelonephritis (APN). However, its clinical...

    Ryutaro Tanizaki, Shuhei Ichikawa, Yousuke Takemura in European Journal of Clinical Microbiology & Infectious Diseases
    Article 01 August 2019
  13. Differences of virulence factors, and antimicrobial susceptibility according to phylogenetic group in uropathogenic Escherichia coli strains isolated from Korean patients

    Background

    Escherichia coli is among the most common uropathogens. Increased antibiotic resistance in Gram negative bacilli is global concern....

    Miri Hyun, Ji Yeon Lee, Hyun ah Kim in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 10 November 2021
  14. A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis

    There is increasing resistance to the oral antibiotics currently recommended for the treatment of pyelonephritis, and increased healthcare costs are...

    Jonathan W. S. Cattrall, Alyss V. Robinson, Andrew Kirby in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 06 September 2018
  15. Inappropriate empirical antibiotic therapy does not adversely affect the clinical outcomes of patients with acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales

    Extended-spectrum β-lactamase-producing Enterobacteriales (ESBL-PE) are often associated with inappropriate empirical therapy (IAT). The aim of this...

    Si-Ho Kim, Suhyun Oh, ... Kyong Ran Peck in European Journal of Clinical Microbiology & Infectious Diseases
    Article 13 March 2019
  16. Intercalated cell function, kidney innate immunity, and urinary tract infections

    Intercalated cells (ICs) in the kidney collecting duct have a versatile role in acid–base and electrolyte regulation along with the host immune...

    Andrew L. Schwaderer, Evan Rajadhyaksha, ... David S. Hains in Pflügers Archiv - European Journal of Physiology
    Article 16 January 2024
  17. A physiatrist’s role in managing unique challenges in pregnancy and delivery in a patient with incomplete lumbar SCI: a case report

    Introduction

    Women of childbearing age make up around 5–10% of individuals with spinal cord injury (SCI) and may face unique medical and functional...

    Lauren Hall, Connie Hsu, ... John Lowry in Spinal Cord Series and Cases
    Article 04 June 2024
  18. White Cell Casts

    Reference work entry 2024
  19. Management of neurogenic bladder in patients with spinal cord injuries/disorders and end stage renal disease: a case series

    Introduction

    Patients with spinal cord injuries/disorders (SCI/D) often suffer from bladder dysfunction, commonly referred to as neurogenic bladder or...

    Rajbir Chaggar, Lance L. Goetz, ... Jeffrey Tubbs in Spinal Cord Series and Cases
    Article Open access 04 March 2024
  20. Genetic and Molecular Mechanisms of Multidrug-Resistance in Uropathogens and Novel Therapeutic Combat

    Urinary tract infections (UTIs) affect the kidney, ureters, bladder, and urethra. UTIs are divided into pyelonephritis (inflammation of kidney),...
    Muhammad Mubashar Idrees, Ali Saeed in Biochemistry of Drug Resistance
    Chapter 2021
Did you find what you were looking for? Share feedback.